THESEUS PHARMACEUTICALS, INC. Operating Lease Cost
THESEUS PHARMACEUTICALS, INC. reported Operating Lease Cost of $414.00 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-17.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2023-11-17
- THESEUS PHARMACEUTICALS, INC. operating lease, cost for the quarter ending 2023-09-30 was $141.00K, a 7.63% increase year-over-year.
- THESEUS PHARMACEUTICALS, INC. operating lease, cost for the quarter ending 2023-06-30 was $138.00K, a 10.40% increase year-over-year.
- THESEUS PHARMACEUTICALS, INC. operating lease, cost for the quarter ending 2023-03-31 was $135.00K.
- THESEUS PHARMACEUTICALS, INC. operating lease, cost for the quarter ending 2022-09-30 was $131.00K.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month |
|---|---|---|---|
| 2023-09-30 | $141.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-17 | $279.00K derived: sum of 2 quarters · filed 2023-11-17 | $414.00K 10-Q · filed 2023-11-17 |
| 2023-06-30 | $138.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $273.00K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $135.00K 10-Q · filed 2023-05-11 | ||
| 2022-09-30 | $131.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-17 | $256.00K derived: sum of 2 quarters · filed 2023-11-17 | $256.00K 10-Q · filed 2023-11-17 |
| 2022-06-30 | $125.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $125.00K 10-Q · filed 2023-08-10 | |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-11 |